More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Amgen stock skidded late Tuesday after the biotech behemoth said the FDA placed one of its obesity treatments on clinical hold.

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

HHS Secretary Robert F. Kennedy Jr. is preparing to remove committee members who advise the government on vaccine approvals ...

Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...

A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

About Zappy Health: Customers say they were drawn to the online provider by its low prices, its lack of subscription fees and ...

President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...

A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...

Nutrition guidelines He has said the nutrition department at the Food and Drug Administration that is ... saying it focused on symptoms of the obesity crisis rather than fixing the food system ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...